LCN2 and portal hypertension: (103) investigated the association of hepatic and systemic LCN2 levels in liver fibrosis, portal hypertension, and disease severity in patients with alcoholic hepatitis and in mouse subjected to ethanol or carbon tetrachloride treatments (103).